• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: UC Davis
  • Amount: $100,642

  • Award Date: March 2021

Table of Contents

    Grant Investigators: Heather Youngs and Chris Somerville

    This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication.

    Open Philanthropy recommended a grant of $100,642 to UC Davis to enable Associate Professor Lark L. Coffey to collaborate with researchers at Duke University and the Weill Cornell Medical College of Cornell University to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

    This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.

    Related Items

    • Scientific Research

      UC Davis — Malaria Gene Drive Feasibility Analysis (Greg Lanzaro) (2021)

      Grant investigator: Chris Somerville and Heather Youngs. This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy...

      Read more
    • Scientific Research

      UC Davis — Malaria Gene Drive Feasibility Analysis (Greg Lanzaro)

      Open Philanthropy recommended a grant of $1,500,000 over 18 months to UC Davis to support a preliminary feasibility analysis of a potential test of gene drives for malaria...

      Read more
    • Scientific Research

      UC Davis — Research on Antiviral Drugs (Koen Van Rompay)

      Open Philanthropy recommended a grant of $206,613 to UC Davis to support a trial led by Koen Van Rompay of an HSP90 inhibitor as a possible treatment for...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!